Author: mrr5831
-
Study Investigates Crosstalk Between Mitochondria and Lysosomes
Northwestern Medicine investigators have discovered that outer mitochondrial membrane proteins regulate crosstalk between mitochondria and lysosomes, findings that have implications for many diseases.
-
Evaluating Treatment Options for Peripheral Artery Disease
Telmisartan, an angiotensin receptor blocker drug, did not improve walking performance in patients with lower extremity peripheral artery disease, according to a recent clinical trial published in JAMA.
-
Study Uncovers Role of Mitochondrial Energy Production in Dopaminergic Neurons
Northwestern Medicine investigators have discovered that dopaminergic neurons in the substantia nigra utilize a specific ion channel to control energy production and meet bioenergetic need, according to a recent study.
-
Investigating the Role of Fatty Acids in Cancer Cell Survival
Northwestern Medicine investigators have discovered that a particular enzyme is essential for regulating cancer cell survival and metastasis under cellular stress, according to a recent study.
-
Northwestern Investigates COVID-19: Sentinel Surveillance, ‘Long COVID’ in Children
Northwestern Medicine investigators continue to investigate the impact of the COVID-19 pandemic, from evaluating repurposed drugs in preventing severe disease to using sentinel surveillance to monitor SARS-CoV-2 transmission rates and studying the prevalence of “long COVID” in pediatric patients.
-
Study Identifies Mechanisms Promoting Bacterial Survival
Northwestern Medicine investigators have uncovered novel regulatory mechanisms that promote bacterial survival, according to findings published in PNAS.
-
Targeting Ion Channels to Manage Osteoarthritis Pain
Therapeutically targeting ion channels in nociceptor neurons may be a promising strategy for managing osteoarthritis pain, according to a Northwestern Medicine study.
-
Celebrating the Future of Medical Education
Faculty, staff and students shared presentations, workshops and discussions on the future of medical education at Feinberg’s 12th annual Medical Education Day, held September 30.
-
First Drug to Reduce Risk of Mortality and Hospitalization in Heart Failure
Dapagliflozin, a sodium-glucose cotransporter 2 inhibitor, reduced the risk of cardiovascular-related morality and hospitalization in patients with heart failure, regardless of ejection fraction, according to a series of clinical trial reports.
-
Gene Loss Enhances Metastasis and Cancer Progression
Investigators discovered that the loss of the gene SLIT2 in circulating tumor cells regulates metastasis of prostate cancer tumors, according to a Northwestern Medicine study.
